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Abstract
Background: The majority of cancer cells have a unique metabolic requirement for methionine that is not observed in
normal, non-tumorigenic cells. This phenotype is described as “methionine dependence” or “methionine stress sensitivity”
in which cancer cells are unable to proliferate when methionine has been replaced with its metabolic precursor,
homocysteine, in cell culture growth media. We focus on the metabolic response to methionine stress in the triple
negative breast cancer cell line MDA-MB-468 and its methionine insensitive derivative cell line MDA-MB-468res-R8.
Results: Using a variety of techniques including fluorescence lifetime imaging microscopy (FLIM) and extracellular flux
assays, we identified a metabolic down-regulation of oxidative phosphorylation in both MDA-MB-468 and MDA-MB-
468res-R8 cell types when cultured in homocysteine media. Untargeted metabolomics was performed by way of gas
chromatography/time-of-flight mass spectrometry on both cell types cultured in homocysteine media over a
period of 2 to 24 h. We determined unique metabolic responses between the two cell lines in specific pathways
including methionine salvage, purine/pyrimidine synthesis, and the tricarboxylic acid cycle. Stable isotope tracer
studies using deuterium-labeled homocysteine indicated a redirection of homocysteine metabolism toward the
transsulfuration pathway and glutathione synthesis. This data corroborates with increased glutathione levels
concomitant with increased levels of oxidized glutathione. Redirection of homocysteine flux resulted in reduced
generation of methionine from homocysteine particularly in MDA-MB-468 cells. Consequently, synthesis of the important
one-carbon donor S-adenosylmethionine (SAM) was decreased, perturbing the SAM to S-adenosylhomocysteine ratio in
MDA-MB-468 cells, which is an indicator of the cellular methylation potential.
Conclusion: This study indicates a differential metabolic response between the methionine sensitive MDA-MB-468 cells
and the methionine insensitive derivative cell line MDA-MB-468res-R8. Both cell lines appear to experience oxidative
stress when methionine was replaced with its metabolic precursor homocysteine, forcing cells to redirect homocysteine
metabolism toward the transsulfuration pathway to increase glutathione synthesis. The methionine stress resistant MDA-
MB-468res-R8 cells responded to this cellular stress earlier than the methionine stress sensitive MDA-MB468 cells and
coped better with metabolic demands. Additionally, it is evident that S-adenosylmethionine metabolism is dependent
on methionine availability in cancer cells, which cannot be sufficiently supplied by homocysteine metabolism under
these conditions.
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Background
Reprogrammed metabolism in cancer has gained greater
attention in recent years, beyond the well-known Warburg
effect [1]. While mechanistic insights into the metabolic
changes in cancer are limited, the importance of
methionine metabolism in cancer cell proliferation has
been known for over 50 years (Fig. 1a) [2]. Early stud-
ies describe a unique metabolic requirement of cancer
for methionine known as the “methionine dependence
phenotype.” The vast majority of malignant cells
experience methionine dependence and cannot prolif-
erate in growth media in which methionine is replaced
by its metabolic precursor, homocysteine. In contrast,
most normal non-tumorigenic cells are unaffected by
culturing in homocysteine media (Fig. 1b) [3].
Methionine is an essential amino acid necessary for
normal growth and cell function. It contributes to protein
synthesis and is the precursor to S-adenosylmethionine
(SAM), the principal methyl donor in the cell. SAM is a
versatile molecule required for methylation of DNA, RNA,
proteins, and lipids by a variety of methyltransferases. In
addition, SAM is critical for the formation of 1-
methylnicotinamide, a primary factor involved in stem cell
pluripotency [4], polyamine biosynthesis [5], and the
methionine salvage pathway [6]. As SAM donates its acti-
vated methyl group in methylation reactions, it is converted
to S-adenosylhomocysteine, which is further hydrolyzed to
homocysteine in a reversible reaction (Fig. 1a) [7]. Homo-
cysteine is a junction metabolite, and its metabolism can be
either directed toward the remethylation pathway to regen-
erate methionine by receiving a methyl group from betaine
or N5-methyltetrahydrofolic acid or toward cysteine and
glutathione synthesis in the transsulfuration pathway [8].
Homocysteine inhabits a critical position where, depending
on demand, metabolic flux can be redirected to increase
methylation potential or produce antioxidants.
Although initial studies suggested methionine limitation
to be responsible for the “methionine dependence pheno-
type,” limited availability of SAM is the actual culprit.
Work by Coalson and colleagues has shown that methio-
nine dependent cells endogenously synthesize methionine
at normal levels in homocysteine media (Met-Hcy+) but
show reduced SAM synthesis [9]. Accordingly, by supple-
menting homocysteine growth medium with SAM, cell
proliferation of methionine-dependent breast cancer
cells can be restored, suggesting SAM limitation as the
cause for methionine dependence [10]. Furthermore,





Fig. 1 Methionine dependency of cancer cells. a Methionine metabolism in mammals: the one carbon cycle is essential to regenerate methionine and
S-adenosylmethionine (SAM). SAM is the major methyl donor in the cell and is involved in reactions for phospholipid synthesis, chromatin, RNA, and
protein methylation, and one carbon donor pool homeostasis. b Illustration depicting the methionine dependency of cancer. Most cancer cells (red)
do not grow in homocysteine growth medium (Met-Hcy+), whereas normal cells (blue) are unaffected. Green arrows indicate positive proliferation rates,
red arrows indicate reduced or no proliferation. c MB468 and MB468res cells proliferate in methionine growth media (Met+) at similar rates. d But only
the resistant cells (MB468res: R8, R21, R28) maintain proliferation in Met-Hcy+ media. Proliferation rates were quantified by luminescent cell viability
assay. Error bars represent standard deviation. e Methionine stress resistant clone MB468res-R8 forms fewer colonies in soft agar than the parental
MB468 cell line. Cells were plated in 0.3 % agar, cultured for 30 days, and stained with crystal violet. Colony values are the average of three independent
experiments. Error bars indicate standard deviation
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adenosyltransferase (MAT), the enzyme responsible for
synthesis of SAM from methionine and ATP, mimics
the cell cycle arrest induced by replacing methionine
with homocysteine in the growth media [10, 11]. The
specific cell cycle arrest in the G1 phase induced by
homocysteine medium or MAT knockdown is reminis-
cent of an evolutionary conserved metabolite respon-
sive cell cycle checkpoint first described in yeast. This
“SAM-checkpoint” was proposed to protect cellular
integrity and maintain epigenetic stability as it halts cell
cycle progression before intracellular SAM concentra-
tions get too low to support the various methylation
reactions necessary for normal cell physiology. Cancer
cells have a highly responsive SAM-checkpoint, likely
because of their higher demand on SAM [10]. Details
of why cancer cells depend on high levels of SAM
remain to be discovered, but their increased prolifera-
tion rate requires constant duplication of chromatin
methylation marks, methylation of RNAs, and SAM-
dependent synthesis of membrane lipids. In addition,
many cancer cells are characterized by hyperactive
polyamine synthesis [12], which consumes SAM. A
decarboxylated form of SAM reacts with the polyamine
putrescine to form spermidine and spermine, generat-
ing the by-product 5′-deoxy-5′-methylthioadenosine
(MTA). Further processing of MTA generates adenine
and replenishes the methionine pool [13]. Although
polyamine synthesis clearly contributes to SAM usage
in cancer cells and modified polyamines, specifically
diacetylspermine, have been shown as clear biomarkers
in lung [14] and colon cancer [15], SAM limitation or
growth in homocysteine media do not imitate effects of
polyamine depletion and cannot be rescued by spermi-
dine supplementation [11, 16].
While some progress has been made by linking methio-
nine dependency of cancer to SAM limitation and induc-
tion of a specific cell cycle arrest, our understanding of
this striking metabolic dependence of cancer remains
minimal. Here, we characterized the dynamics of meta-
bolic changes in breast cancer cells when they are shifted
to homocysteine-based growth media, using untargeted
metabolomics as well as stable isotope-labeled tracer stud-
ies to follow the metabolic fate of homocysteine.
Methods
Cell lines and growth conditions
MDA-MB-468 were maintained in DMEM (Sigma-Aldrich,
D0422) supplemented with 10 % dialyzed FBS (Gemini Bio-
Products), 1.5 μM cyanocobalmin (vitamin B12), 4 mM L-
glutamine, 100 μM L-cysteine (Fisher Scientific), and
100 μM L-methionine (Sigma-Aldrich). In the case of
methionine-free media, 370 μM DL-homocysteine (Sigma-
Aldrich) or 370 μM DL-homocysteine-2H4 (13C Molecular,
12714-158) was added in the absence of methionine.
Resistant cell lines were isolated as described in Hoffman
et al. [17]. Briefly, MDA-MB-468 resistant clones were iso-
lated after prolonged culturing in methionine-free media.
The majority of MDA-MB-468 cells detach; however, re-
sistant clones begin to appear after 2 weeks. Clones were
isolated, and proliferation rates were measured using
CellTiter-Glo luminescent cell viability assay (Promega).
Both MD468 and MB468res-R8 cell lines were tested
for authentication via STR profiling in January 2016 by
Genetica DNA Laboratories (a LabCorp brand; Burlington,
NC) using the commercially available PowerPlex® 16HS
amplification kit (Promega Corporation) and GeneMapper
ID v3.2.1 software (Applied Biosystems). Authentication of
each cell line was confirmed by a 100 % match to the refer-
ence STR profile of MDA-MB-468 (ATCC HTB-132) cells
from ATCC.
Anchorage independence assay
To detect anchorage independence of transformed cells,
MDA-MB-468 and resistant cell lines were cultured in
soft agar for 30 days. Each assay was conducted in a 35-
mm Petri dish with a 0.5 % agar base layer and 0.35 % agar
top layer prepared using low-gelling-temperature agarose
(Sigma, A9045) in methionine growth media. The top
layer of each assay contained 5000 cells except for control
plates. Assays were maintained at 37 °C in a humidified
incubator, and 0.5 ml methionine growth media was
added to each plate twice weekly. Colonies were stained
with 0.005 % crystal violet for 1 h, washed once with PBS,
and manually counted.
Preparing cells for metabolite extraction
Cells were harvested by first washing attached cells with
10 ml PBS before adding 0.5 % trypsin (Life Technologies,
25300-054) for 10 min and incubating at 37 °C. Cells were
collected in complete DMEM (4 °C) without methionine or
homocysteine and centrifuged (300×g, 5 min, 4 °C); from
this point on, cells were kept on ice during all processing
steps. Cell pellets were washed with 10 ml PBS (4 °C) and
counted. The appropriate number of cells was aliquoted
and centrifuged (300×g, 5 min, 4 °C). Cell pellets were
resuspended in 1 ml PBS (4 °C), transferred to a pre-
weighed microcentrifuge tube, and centrifuged (300×g,
5 min, 4 °C). PBS was aspirated, and cell pellets were
weighed before flash freezing in liquid nitrogen.
Samples were stored at −80 °C until shipped on dry
ice. This protocol was performed as described in
T.W.-M. Fan et al. [18].
Immunoblots
MDA-MB-468 and MDA-MB-468res-R8 cells were cul-
tured in methionine or homocysteine media for 24, 48, 72,
and 96 h. Lysates were prepared in 8 M urea buffer (8 M
urea, 200 mM NaCl, 0.2 % SDS, 100 mM Tris (pH 7.5),
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1 mM PMSF, 1 ng/ml aprotinin) and resolved by 10 %
SDS-PAGE. Protein levels were detected by immunoblot
using MAT2A (Abcam, ab77471) and MAT2B (Abcam,
ab86506) antibodies.
FLIM acquisition and phasor data analysis
MDA-MB-468 and MDA-MB-468res-R8 cells were cul-
tured in methionine or homocysteine media. To inhibit
oxidative phosphorylation, cells were treated with 4 mM
potassium cyanide (KCN) for 5 min before imaging.
Fluorescence lifetime imaging microscopy (FLIM) was
performed on Zeiss LSM 710 microscope (Carl Zeiss,
Jena, Germany) using a ×40 water immersion objective,
1.2 N.A. (Carl Zeiss, Oberkochen, Germany) coupled
with two-photon excitation of 740 nm (titanium:sapphire
MaiTai laser from Spectra-Physics, Mountain View, CA).
Image scan speed was 25.21 μs/pixel, and image size is
256 × 256 pixels. The emission signal was collected using
a 460/80-nm bandpass filter and photomultiplier tube
(H7422P-40, Hamamatsu, Japan) was used for detection.
FLIM data was acquired using A320 FastFLIM FLIMbox
(ISS, Champaign, IL). SimFCS software, developed at the
Laboratory for Fluorescence Dynamics (LFD, UC Irvine),
was employed for both FLIM data acquisition and ana-
lysis. FLIM-phasor approach was used for phasor ana-
lysis, as described previously [19, 20]. Briefly, lifetime
information from every pixel of the image is transformed
into a phasor and plotted on a phasor plot. This can be
mapped back onto the image to create the FLIM map.
Extracellular flux (XF) analyses
All XF analyses were performed on the Seahorse Bioscience
XF24 Extracellular Flux Analyzer (Seahorse Bioscience,
North Billerica, MA) using the manufacturer’s protocol.
Cells were plated in 24-well Seahorse XF-24 assay plates at
a density of 90,000 cells per well in Met+ media (as de-
scribed above). After 6 h, eight wells were washed with pre-
warmed PBS before Met+ media and Met-Hcy+ media
were added in four wells each. This process was repeated
for the 8, 4, and 2 h time points. One hour before metabolic
flux analysis, cells were washed once with un-buffered,
serum-free media (Caisson Labs, DMP39-10XLT) contain-
ing 100 uM methionine or 370 μM DL-homocysteine and
incubated with un-buffered media at 37 °C in a non-
CO2 incubator for 1 h. Four baseline oxygen consump-
tion rate (OCR) and extracellular acidification rate
(ECAR) measurements were taken before sequential in-
jection of the following mitochondrial inhibitors: oligo-
mycin (1 μg/ml), carbonyl cyanide-4-phenylhydrazone
(FCCP) (0.4 μM), and rotenone (0.1 μM). Four mea-
surements were taken after the addition of each inhibi-
tor, and OCR and ECAR values were automatically
calculated and recorded by the Seahorse XF-24 soft-
ware. Basal respiration was calculated by averaging the
four measurements of OCR before injection of inhibi-
tors. Basal ECAR values were calculated in the same
manner. Spare respiration capacity was calculated by
subtracting basal OCR values from OCR values after
FCCP treatment.
Metabolomics analysis
The MiniX database [21] was used as a Laboratory
Information Management System (LIMS) and for sam-
ple randomization prior to all analytical procedures.
GCTOFMS analysis
For analysis of primary metabolism, cell lysates, stored at
−80 °C, were thawed on ice, extracted, and derivatized and
metabolite levels were quantified by gas chromatography
time-of-flight (GC-TOF) mass spectrometry (MS) as previ-
ously described [22]. Acquired spectra were further proc-
essed using the BinBase database [21, 23]. Briefly, output
results [24] were filtered based on multiple parameters to
exclude noisy or inconsistent peaks. All entries in BinBase
were matched against the Fiehn mass spectral library of
1200 authentic metabolite spectra using retention index
and mass spectrum information or the NIST14 commercial
library. Data, reported as quantitative ion peak heights,
were normalized by the sum intensity of all annotated
metabolites (Eq. 1) and used for further statistical analysis.
metaboliteij;normalized ¼ metaboliteij; raw=mTICj
 mTIC average ð1Þ
HILIC-UHPLC-qTOFMS analysis
For analysis of biogenic amines, cell lysates, stored
at −80 °C, were thawed on ice and extracted with ice-cold
“degassed” 3:3:2 acetonitrile/isopropanol/ultra-pure water.
Supernatant-containing extracted metabolites were dried
to completeness under reduced pressure and resus-
pended in 60 μL of 80:20 ACN/H2O containing an
internal Val-Tyr-Val (Sigma-Aldrich). Resuspended sam-
ples were analyzed on an Agilent 1290A Infinity Ultra
High Performance Liquid Chromatography system with
an Agilent Accurate Mass-6550-QTOF mass spectrom-
eter. The column (45 °C) was a Waters Acquity UPLC
BEH (150-mm length × 2.1-mm internal diameter; 1.7-μM
particles) coupled with a Waters Acquity VanGuard BEH
C18 Pre-column (50-mm length × 2.1-mm internal diam-
eter; 1.7-μM particles). The solvent system included (A)
100 % water (LCMS grade) containing 10 mM ammonium
formate and 0.125 % formic acid and (B) 95:5 v/v aceto-
nitrile to water containing 10 mM ammonium formate
and 0.125 % formic acid. The gradient started from 0 min
100 % (B), 0–2 min 100 % (B), 2–7.7 min 70 % (B), 7.7–
9.5 min 40 % (B), 9.5–10.25 min 30 % (B), 10.25–
12.75 min 100 % (B), and 12.75–16.75 min 100 % (B). The
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flow rate was 0.4 mL/min and with an injection volume of
5 μL. ESI capillary voltage was +3.5 kV with collision ener-
gies of 20 eV MSMS collection in positive acquisition
mode. Data was collected at a mass range of m/z 60–
1700 Da with a spectral acquisition speed of 4 spectra per
second.
Data was processed using MZmine 2.10 software. Me-
tabolites were identified by searching against a precursor
accurate mass and retention time library in conjunction
with matching tandem mass spectra against the LipidBlast
virtual MS/MS database [25]. Data are reported as peak
heights for the quantification ion (m/z) at the specific re-
tention time for each annotated and unknown metabolite.
Stable isotope tracer studies
Evaluation of methionine, homocysteine, and cystathionine
enrichment
Cells were extracted with ice-cold 1 ml of degassed 3:3:2
acetonitrile/isopropanol/ultra-pure water, the supernatant
removed, and solvents evaporated to dryness under re-
duced pressure. To remove membrane lipids and triacylgly-
cerides, dried samples were reconstituted with acetonitrile/
water (1:1), decanted, and taken to dryness under reduced
pressure. Samples were derivatized with methoxyamine
hydrochloride in pyridine and subsequently by MTBSTFA
(Sigma-Aldrich) and analyzed by gas chromatography mass
spectrometry.
An Agilent 7890A gas chromatograph (Santa Clara, CA)
was used with a 30 m × 0.25-mm i.d. (internal diameter) ×
0.25 μM HP-5 MS Column (Agilent J&W GC Columns).
An Agilent 7693 auto-sampler was used to eliminate
cross-contamination during GCMS analysis. One micro-
liter (1 μl) of sample was injected at 60 °C (ramped to
250 °C) in splitless mode with a 30-s purge time. The
chromatographic gradient consisted of a constant flow of
1 mL/min, ramping the oven temperature from 60 to
350 °C over 37 min. Mass spectrometry was done using
an Agilent 5977A MSD spectrometer, 290 °C transfer line
temperature, electron ionization at −70 eV, and an ion
source temperate of 230 °C. Mass spectra were acquired
at 1555 V at m/z 50–600 with 2.7 spectra/s.
Acquired spectra were converted to netCDF files using
vendor (Agilent) software and submitted for non-
targeted enrichment analysis using the Non-targeted
Fate Detection Software version 1.1 [26]. Spectrum of
enriched peaks was manually compared against refer-
ence spectrum-derived authentic standard and from par-
allel experiments using non-labeled homocysteine.
Enrichment due to presence of deuterium was vali-
dated using a secondary independent mass isotopomer
distribution (MID) analyzer developed at the West Coast
Metabolomics Center. MID calculations were deter-
mined using a modified least-squares linear regression
matrix modeled after Jennings et al. [27]; corrected for
natural abundance; and reduced isotopic probability with
increasing deuterium enrichment. MID values are re-
ported as fractional proportions (1 = 100 % enriched)
that the respective mass isotopologue contributes to the
overall abundance of the respective analyte.
Evaluation of SAM and SAH enrichment
SAM and S-adenosylhomocysteine (SAH) levels were
determined by hydrophilic interaction liquid chromatog-
raphy ultra high pressure liquid chromatography accur-
ate mass quadrupole time-of-flight mass spectrometry
(HILIC-UHPLC-qTOFMS) as described above. Enrich-
ment due to presence of deuterium was determined
using the MID analyzer as described above. Spectrum of
enriched peaks was manually compared against refer-
ence spectrum-derived authentic standard and from par-
allel experiments using non-labeled homocysteine.
Results and discussion
A methionine-dependent and methionine-independent
breast cancer cell line pair
The majority of malignant cells exhibit the methionine-
dependent phenotype as indicated by cell cycle arrest
and apoptosis when cultured in media where methionine
(methionine media (Met+)) is replaced with the immediate
metabolic precursor homocysteine (homocysteine media,
Met-HCY+) [3, 28, 29]. Although methionine dependence
is specific for cancer cells and non-tumorigenic cells prolif-
erate well in homocysteine medium, long-term culturing of
malignant cell lines in Met-Hcy+ can select methionine-
independent, methionine stress resistant clones [10, 30].
The data presented in this study focuses on the triple nega-
tive breast cancer cell line MDA-MB-468 (shortened to
MB468) due to our ability to derive multiple methionine
stress resistant clones (MB468res) as controls [10]. These
methionine stress resistant cells propagate at similar rates
as the parental MB468 cell line when cultured in methio-
nine growth medium; however, MB468res cells continue to
proliferate in Met-Hcy+ medium unlike MB468 cells
(Fig. 1c, d). Spontaneous reversion to methionine inde-
pendence has been associated with loss of transformation-
specific properties such as anchorage independence [31].
We therefore tested whether phenotypes associated with
tumorigenicity are also lost in MB468res cells. When cul-
tured in soft agar with Met+ growth media, MB468 cells ef-
ficiently formed colonies consistent with their tumorigenic
phenotype. In contrast, MB468res-R8 cells formed only few
or very small colonies (Fig. 1e), indicating a loss of the
transformation phenotype. Similar results were obtained
with the MB468res-R21 and R28 lines. However, whereas
R8 and R21 did not form colonies, the R28 line formed nu-
merous tiny colonies scarcely visible with the naked eye.
We continued our studies with the MB468res-R8 cell line
as their proliferation rate in Met+ medium is closest to the
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parental MB468 cell line, which eliminates potential effects
on metabolite demand due to growth rate differences.
MB468res-R8 cells provide an excellent control for our in-
vestigation of methionine dependence because cell morph-
ology, proliferation rate, growth medium requirements, and
genetic background resemble those of methionine stress
sensitive MB468 cells. The molecular mechanism of rever-
sion to methionine independence is unknown. Reversion is
an extremely rare event and stable for several generations.
However, after several generations, MB468res-R8 cultures
can revert back to methionine dependence, suggesting epi-
genetic mechanisms behind this phenomenon.
Homocysteine media induces a metabolic
down-regulation of oxidative phosphorylation
To monitor metabolic states in MB468 cells and their
methionine-independent derivatives, MB468res-R8, we
employed FLIM. Using two-photon excitation at 740 nm,
we measured the intrinsically fluorescent molecule-reduced
nicotinamide adenine dinucleotide (NADH) in live cells
(Fig. 2a). NADH is a powerful biomarker for the metabolic
state of the cell as it is the principal electron donor in gly-
colysis and electron acceptor in oxidative phosphorylation
[32]. Phasor analysis of NADH FLIM data gives spatial dis-
tribution of free to protein-bound NADH [19, 20, 33]
(Fig. 2b). Importantly, FLIM analysis is different from the
intensity ratio at two different emission wavelengths, which
is commonly used to correlate with metabolism. In the
FLIM analysis, only NADH in the bound and free form is
measured by proper selection of excitation and emission
wavelengths. More importantly, the FLIM technique is
based on fluorescence lifetime, which is independent of
the total concentration of NADH, contrary to the com-
mon dual wavelength emission ratio. In our analysis,
we determine directly the free to bound (to proteins)
ratio. Protein-bound NADH is characterized by longer
fluorescence lifetimes, influenced by binding to various
enzymes. In contrast, shorter fluorescence lifetimes of
NADH indicate a higher fraction of NADH that is not
bound to proteins [34]. By measuring the NADH phasor
distribution along the metabolic trajectory on the phasor
plot, we can calculate the free/bound NADH ratio [35]. A
series of previous experiments have shown that low free/
bound NADH ratios are characteristic for cells actively
engaged in oxidative phosphorylation, whereas higher
free/bound ratios indicate increased dependence on gly-
colysis for energy production (Fig. 2c) [19, 20, 36].
We compared fluorescence lifetimes of NADH from
both MB468 and MB468res-R8 cells cultured in Met+
and Met-Hcy+ media. We used phasor cluster analysis
to quantify the signals of higher and lower free/bound
NADH ratios of both cell lines (Fig. 2d). In Met+ media,
both cell lines had similar profiles with approximately
80 % of the signal representing a lower free/bound ratio
providing a baseline for oxidative phosphorylation activity
in these cell types (Fig. 2e). After 48 h, cells were trans-
ferred to Met-Hcy+ media; 70 % of the MB468 and 64 %
of the MB468res-R8 signal represented the lower free/
bound NADH ratio and thus a reduction in cellular respir-
ation. Importantly, the addition of potassium cyanide, a
potent inhibitor of mitochondrial respiration, resulted in a
decrease in the signal of the lower free/bound ratio, simi-
lar to culturing in Met-Hcy+ media alone (Fig. 2a, e). The
similar metabolic trajectories of potassium cyanide-treated
cells and Met-Hcy+ cultures suggest that methionine
stress may affect mitochondrial function or force cells to
reduce oxidative phosphorylation.
We further analyzed mitochondrial function using an
extracellular flux (XF) analyzer, which measures OCR as
an indicator for mitochondrial respiration. Both MB468
and MB468res-R8 cells were cultured in either Met+
media for 12 h or Met-Hcy+ media for 2, 4, 8, and 12 h
prior to measuring basal levels of OCR (Fig. 2f). Within
4 h in Met-Hcy+ media, both MB468 and MB468res-R8
cell lines respond by transiently increasing OCR. However,
after 8 h, both cell lines showed decreased respiration,
which continued to decline. Interestingly, we observed the
MB468res-R8 cells to have a faster decline in respiration
as compared to MB468 cells. In additional analyses with
the XF analyzer, spare respiration capacity was measured
in MB468 and MB468res-R8 cells cultured in Met+ media
and treated with the electron transport chain accelerator
FCCP. MB468 cells can maximize OCR 1.9 times that of
basal levels when stressed with FCCP, whereas MB468res-
R8 cells have a maximum 1.5-fold increase of OCR under
the same conditions. We hypothesize that the faster de-
cline in mitochondrial respiration in Met-Hcy+ media
(Fig. 2f) and the reduced effect of KCN in the FLIM ana-
lysis (Fig. 2e) as compared to MB468 cells may be due to
an innate lower capacity for respiration. With a smaller re-
served respiration capacity, MB468res-R8 cells may feel
the effects of dysfunctional mitochondria sooner but may
not be as reliant on oxidative phosphorylation resulting in
improved tolerance of metabolic stress as compared to
MB468 cells. Regardless of these differences, the general
response of both cell lines to Met-Hcy+ media and KCN
is comparable, indicating reduced mitochondrial respir-
ation during culturing in Met-Hcy+ media as determined
by both FLIM and XF analyses.
Metabolite changes associated with culturing in
homocysteine media
FLIM and XF analyses indicated that cells change their
metabolism in response to homocysteine medium. These
results prompted us to investigate the immediate meta-
bolic response to homocysteine media. Both MB468 and
MB468re-R8 were cultured in Met+ media or transi-
tioned to Met-Hcy+ media for 2, 4, 8, 12, and 24 h, and
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metabolites were analyzed by an untargeted metabolo-
mics approach using gas chromatography/time-of-flight
mass spectrometry (Fig. 3a). Immediate changes in select
metabolites are observed for both cell lines, albeit with
distinct trends. Interpretation of differential changes of
metabolite concentrations between the two cell lines at
the later time points is complicated by the fact that
MB468 cells respond with cell cycle arrest whereas
MB468re-R8 cells continue to proliferate. It is thus diffi-
cult to distinguish between changes due to homocysteine
growth media and changes caused by the block in prolif-
eration. However, metabolite concentration changes at
the early time points cannot be indirect consequences of





Fig. 2 Homocysteine media induces a metabolic shift from oxidative phosphorylation to glycolysis. a MB468 and MB468res-R8 cells cultured in
Met+ or Met-Hcy+ growth media for 48 h with or without 4 mM KCN were imaged using two-photon microscopy at 740 nm. NADH free/bound
fluorescence lifetime imaging microscopy (FLIM) maps of cells are shown using the color spectrum in the FLIM phasor histogram (b). c The phasor
histogram represents relative fractions of free NADH (cyan-white) and protein-bound NADH (red-purple). d Cluster analysis using the phasor histogram
to separate signals of high free/bound (black square) and low free/bound (pink square) NADH ratios. e Quantitation of NADH ratios from cells in a is
shown. Two fields for each sample with a minimum of 15 cells per field were analyzed by cluster analysis and normalized to total pixels measured. The
black dotted line indicates the average percentage of lower free/bound NADH ratios of MB468 (80 %) and MB468res-R8 (79 %) cells cultured in in Met+,
KCN(−). f MB468 and MB468res-R8 cells cultured in Met+ media for 12 h or Met-Hcy+ media for 2, 4, 8, and 12 h were analyzed by Seahorse Bioscience
XF analyzer. MB468 (blue line with squares) and MB468res-R8 (black line with circles) basal oxygen consumption rates (OCR) are shown normalized to
the Met+-treated sample. Error bars represent normalized standard deviation, n = 4 replicates; statistical differences between Met+ media and Met-Hcy
+ media treatments are indicated by asterisk where p ≤ 5.0 × 10−7
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Fig. 3 Homocysteine media induces a metabolic response in MB468 and MB468res-R8 cells. MB468 and MB468res-R8 cells were cultured in Met+
or Met-Hcy+ media over the course of 24 h and analyzed by untargeted UHPLC- and GCMS-based methodologies (see “Methods” section).
a Heatmaps representing metabolites measured in both MB468 and MB468res-R8 cells. Metabolites are color filled based on fold change to
the Met+, time-zero sample. Yellow indicates a decrease in metabolite abundance and blue indicates an increase as compared to time-zero
control. b, c Pathways enriched within 4 h of culturing in Met-Hcy+ media. Metabolites with significantly different abundance at 2 and 4 h as
compared to time zero were determined using the Bayesian t test, Cyber-T [37, 38], with a Benjamini-Hochberg p ≤ 0.05. Enriched pathways
were determined using the web server Metabolite Biological Role (MBRole) with a raw p value cutoff at p ≤ 0.1 [39]
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substantially longer [10]. Interestingly, the general trends
of metabolite concentration changes between the cell lines
seem to project into different directions. In MB468 cells,
several metabolites responded within 4 h with a general de-
crease in abundance as compared to Met+-cultured cells.
In contrast, the majority of metabolites in MB468res-R8
cells that responded within 4 h increased in their abun-
dance. Pathway analysis using the web server Metabolite
Biological Role showed that within 4 h of culturing in Met-
Hcy+ media, fewer pathways are affected in MB468 cells as
compared to MB468res-R8 (Fig. 3b, c) [37–39].
Metabolites connected to methionine
We next looked at individual metabolic pathways in more
detail. Changes in metabolite levels associated with
methionine stress are evident in both MB468 and
MB468res-R8 cell lines as early as 2 h after switching to
Met-Hcy+ media. Several metabolite concentration changes
occurred in both the methionine-dependent (MB468) and
methionine-independent (MB468res-R8) cell lines and
reflect a general response to homocysteine becoming the
primary source of sulfur amino acids. Metabolite responses
with distinct patterns in the two cell lines were particularly
evident for metabolites connected to the methionine
salvage pathway and purine/pyrimidine synthesis (Fig. 4).
We found a striking response in levels of 5′-deoxy-5′-
methylthioadenosine (MTA) and adenine, the two SAM-
derived metabolites in the methionine salvage pathway.
Both MTA and adenine decreased rapidly in MB468 cells
but not in MB468res-R8 (Fig. 4a). MTA is the by-product
of polyamine synthesis, and adenine is released as MTA is
recycled into methionine (Fig. 4b). MTA and adenine con-
centrations decreased to about one fifth of the starting con-
centration within 2 h after MB468 cells were shifted to
Met-Hcy+ medium and recovered somewhat to about 60 %
of starting levels after 24 h. Surprisingly, even though the
rapid and dramatic reduction in MTA and adenine levels
suggest repression of polyamine synthesis, the levels of pu-
trescine and spermidine remained largely unchanged over
the time course (Fig. 4b). It is possible that the amount of
polyamines synthesized over the 24 h period we monitored
does not significantly contribute to the total polyamine pool
in cells. However, the decrease in MTA production clearly
reflects a physiological response of MB468 cells to methio-
nine stress and suggests that cells attempt to preserve SAM
concentrations by repression of polyamine synthesis. In
contrast, MB468res-R8 cells appear to up-regulate poly-
amine synthesis indicated by doubling of spermidine abun-
dance within 2 h and a correction to starting levels after
24 h. MTA and adenine levels show a similar increase in
abundance over 2 h and continue to increase after 24 h to
almost twice the starting levels.
The differences in the levels of MTA may contribute to
the difference in methionine levels between the two cell
lines. MB468 cells have a slight decrease in methionine
starting at 2 h, staying around 0.7-fold abundance until
24 h when the levels decrease to half the starting quantity
(Fig. 4b). MB468res-R8 cells increase in methionine levels
as early as 2 h but return to normal after 8 h. It is import-
ant to note that the MB468res-R8 cells continue to prolif-
erate in Met-Hcy+ media unlike the MB468 cells, which
may affect the use of metabolites in each cell line after
24 h, the approximate doubling time of these cells. How-
ever, the early changes we observed can be attributed to a
metabolic response to the switch from methionine to
homocysteine in the growth medium.
Purines and pyrimidines
Both adenine and adenosine are by-products of the methio-
nine salvage and remethylation pathways and are essential
components in purine synthesis. With few exceptions,
changes in purine as well as pyrimidine concentrations
were not evident until 12 to 24 h after cells were shifted
(Fig. 4c). In MB468res-R8 cells, only adenine increased to
approximately 1.5-fold of the starting quantity within 2 h.
After 12 and 24 h, inosine, inosine monophosphate, and
hypoxanthine were significantly increased (Fig. 4d). In con-
trast, MB468 cells respond to Met-Hcy+ medium with a
delayed decrease in inosine, guanine, and guanosine, as well
as an immediate steep decrease in adenine levels as de-
scribed above. Unlike the overall increase in purines in
MB468res-R8 cells, many purines in MB468 cells decrease
to half the starting quantity by 24 h. Interestingly, the
changes in components of the purine synthesis pathway are
not observed for the pyrimidines thymine and cytosine. In
both MB468 and MB468res-R8 cells, thymine and cytosine
abundance indicate a minimal response to methionine
stress. Uracil, the pyrimidine derivative found in RNA,
showed a comparable trend to the purine response in both
cell lines as levels decrease in MB468 cells and increase in
MB468res-R8 cells over the course of 24 h (Fig. 4d).
Glycolysis and citric acid cycle
Despite major changes in other biochemical pathways,
Met-Hcy+ media had minimal effects on the abundances
of metabolites involved in glycolysis (Fig. 5a). Both MB468
and MB468res-R8 cells indicate only slightly decreased
abundances in glucose and glucose 6-phosphate. More
noticeable differences between the two cell lines were ob-
served in fructose 6-phosphate and pyruvate. Unlike
MB468res-R8, abundances of fructose 6-phosphate and
pyruvate in MB468 indicated initial reductions post media
switch followed by partial equilibration back toward base-
line levels (Fig. 5b). Using the XF analyzer to further
evaluate glycolysis, we treated MB468 and MB468res-R8
cells in Met+ media for 12 h or Met-Hcy+ media for 2, 4,
8, and 12 h and measured the ECAR, an indicator of gly-
colysis (Fig. 5c). Similar to many of the metabolite profiles,
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Fig. 4 (See legend on next page.)
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an initial decrease in glycolysis occurs within 2 h post
media switch followed by partial recovery to baseline.
MB468 cells decrease glycolysis at 2 h to 75 % baseline
with an average partial recovery to 82 % over the next
10 h. MB468res-R8 cells follow a similar trend with a
decrease in glycolysis to 83 % baseline at 2 h and average
recovery to 87 % thereafter. These subtle changes in gly-
colysis suggest an early partitioning of glucose toward the
pentose phosphate pathway for generation of NADPH
(not detected) following the switch to Met-Hcy+ media.
Similar to our earlier observations of decreased mito-
chondrial respiration in Met-Hcy+ media (Fig. 2), the
tricarboxylic acid (TCA)-related metabolites succinate,
fumarate, and malate indicate general reductions in
MB468 cells. In contrast, MB468res-R8 cells show a
twofold increase in malate and fumarate with less strik-
ing increases in other TCA cycle components including
citrate, succinate, and aconitate (Fig. 5b). The reduction
in MB468-dependent TCA intermediates corroborates
with decreased oxidative phosphorylation; however, the
difference in response of MB468res-R8 may be a result
of their lower respiration capacity and thus their reduced
dependence on respiration in these cells.
Homocysteine metabolism is redirected during HCY
culturing
The changes in steady state levels of metabolites are in-
formative and indicate a significant rewiring of meta-
bolic pathways in response to methionine stress and
highlight different metabolic responses in methionine-
dependent and methionine-independent cell lines. How-
ever, interpretations of steady state level changes are
complicated by reversibility of reactions, such that path-
way activities or flux changes can only be inferred in
some situations. The methionine dependence of cancer
is closely linked to the availability of SAM as a co-factor
for methylation, which is also illustrated by the complete
suppression of growth inhibition of MB468 cells cul-
tured in Met-Hcy+ supplemented with SAM [10]. We
therefore asked how homocysteine is used in cells over
time with particular focus on remethylation and trans-
sulfuration (Fig. 6a). To this end, we used deuterium-
labeled homocysteine (d4Hcy = Hcy-d4(3,3,4,4)) to replace
methionine in the cell growth media (Fig. 6b). Both
MB468 and MB468res-R8 cells accumulated d4Hcy to
about the same extent confirming that uptake of homo-
cysteine cannot account for methionine stress sensitivity
(Fig. 6c). Methionine flux analyses have shown that gen-
erally homocysteine remethylation and entry into the
transsulfuration pathway each accounts for approxi-
mately 50 % [40, 41]. Surprisingly, post Met-d4Hcy+
media switch, the majority of homocysteine metabolism
in both MB468 and MB468res-R8 is predominantly di-
rected toward the transsulfuration pathway as indicated
by the almost complete dominance of deuterated cysta-
thionine (transsulfuration) after 24 h and underrepresen-
tation of deuterated methionine (Fig. 6d, e). However,
this effect was significantly delayed in MB468 cells. The
methionine stress resistant MB468res-R8 cells showed a
complete shift to deuterated cystathionine within 4 h of
the media switch, whereas methionine stress sensitive
MB468 cells required at least 24 h in Met-d4Hcy+ medium
to show a comparable transition to deuterated cystathio-
nine. These studies also revealed that MB468res-R8 cells
use homocysteine to remethylate an average of 13 % more
methionine molecules as compared to MB468 cells, a
difference that is reflected in labeled SAM levels as well
(Fig. 6f).
It is interesting to note that while MB468res-R8 cells
process homocysteine forward through the remethyla-
tion pathway, MB468 cells process an average of 6 %
more homocysteine through the reversible hydrolytic
activity of S-adenosylhomocysteine hydrolase (Fig. 6g).
SAH is the by-product of all biological transmethylation
reactions requiring SAM and is also generated from
homocysteine and adenosine. This reverse processing of
homocysteine in MB468 cells may partially contribute to
the decrease in adenosine abundance (Fig. 6h). Compar-
ing the relative concentration of SAM and SAH can
indicate the methylation potential of the cell. However,
it has been shown that a reduced ratio bares little conse-
quence without a corresponding increase in SAH [42,
43]. In both MB468 and MB468res-R8 cells, SAM and
SAH were measured over a 24-h period in Met-Hcy+
media (Fig. 6i). For both cell lines, the SAM to SAH
ratio decreased within 2 h of the media switch. In
MB468 cells, this decrease in SAM to SAH is a result of
a simultaneous decrease in SAM to less than one fifth
(See figure on previous page.)
Fig. 4 Metabolite changes linked to methionine and nucleoside metabolism. a MB468 and MB468res-R8 cells were cultured in Met+ or Met-Hcy+
media over the course of 24 h and analyzed by untargeted GCTOFMS and HILIC-UHPLC-qTOFMS-based metabolomics. Heatmaps represent fold
changes of metabolites in the purine salvage as compared to the Met+, time-zero sample. Metabolites are color filled by fold change: yellow indicates
a decrease in metabolite abundance and blue indicates an increase as compared to time-zero control. b Schematic of polyamine synthesis and methionine
regeneration by way of the methionine salvage pathway. Metabolites with gray arrows are pointing to line graphs of the corresponding metabolite
abundances in MB468 (blue line with squares) and MB468res-R8 (black line with circles) cells. Peak height reflecting relative metabolite abundance is
marked on the y-axis and hours in homocysteine are marked on the x-axis. Error bars represent standard deviation. c Heatmaps represent fold changes
of metabolites involved in purine/pyrimidine synthesis. Color fill is the same as a. d Schematic of purine synthesis and pyrimidines with corresponding
metabolite abundances, same as b
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C
Fig. 5 Metabolite changes in glycolysis and the TCA cycle associated with methionine stress. a MB468 and MB468res-R8 cells were cultured in
Met+ or Met-Hcy+ media over the course of 24 h and analyzed by untargeted metabolomics as described for Fig. 4. Heatmaps represent fold
changes of metabolites in glycolysis and the tricarboxylic acid (TCA) cycle as compared to the Met+, time-zero sample. Metabolites are color filled
by fold change: yellow indicates a decrease in metabolite abundance and blue indicates an increase as compared to time-zero control. b Schematic of
glycolysis and the TCA cycle. Metabolites with gray arrows are pointing to line graphs of the corresponding metabolite abundances in MB468 (blue line
with squares) and MB468res-R8 (black line with circles) cells. Peak height reflecting relative metabolite abundance is indicated on the y-axis and hours in
homocysteine are indicated on the x-axis. Error bars represent standard deviation. Metabolites included in the heatmaps (a) are outlined in a dashed
box. c MB468 and MB468res-R8 cells cultured in Met+ media for 12 h or Met-Hcy+ media for 2, 4, 8, and 12 h were analyzed by the Seahorse Bioscience
XF analyzer. MB468 (blue line with squares) and MB468res-R8 (black line with circles) basal extracellular acidification rates (ECAR) are shown normalized to
the Met+-treated sample. Error bars represent normalized standard deviation, n= 4 replicates; statistical differences between Met+ media and Met-Hcy+
media treatments are indicated by asterisk where p ≤ 0.002
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starting quantity and increase in SAH to 1.5 times the
starting quantity. After 12 h, however, both SAH and
SAM begin to recover toward starting levels. In contrast,
the SAM to SAH decrease observed in MB468res-R8
cells is a result of SAM levels declining to half the start-
ing quantity with minimal perturbations in SAH. Con-
sidering SAM levels are twofold greater in MB468 cells
in Met+ media as compared to MB468res-R8 cells, the
consequences of an altered SAM to SAH ratio and ele-
vated SAH levels in MB468 cells on the methylation po-
tential of the cell may play an important role in
methionine sensitivity. Clearly, both cell lines experience
limited methylation potential as indicated by feedback
up-regulation of methionine adenosyltransferase (MAT),
the enzyme that produces SAM from methionine and
ATP (Fig. 6j). Although labeled methionine levels are
higher in MB468res-R8 cells, in both cell lines, it appears
that the catalytic MAT2A subunit is, for unknown reasons,
unable to use the available methionine for SAM synthesis
and therefore protein levels increase to compensate this
deficiency. Interestingly, MAT2B, the regulatory subunit of
the enzyme, is unaffected by methionine perturbations.
Homocysteine and its relationship to ROS, mitochondria,
and oxidative stress
Transsulfuration is critical to maintain the cellular redox
balance as this metabolic pathway leads directly to gluta-
thione synthesis (Fig. 6a). Interestingly, signaling path-
ways in yeast that are activated by methionine or SAM
limitation induce a massive increase in glutathione syn-
thesis suggesting a common physiological response to
methionine stress in yeast and mammals [44–47]. Ac-
cordingly, the redirection of homocysteine metabolism
to the transsulfuration pathway suggests the activation
of a protective mechanism in response to Met-Hcy+
media. Under normal culturing conditions, the majority
of cellular glutathione exists in its reduced form (GSH).
As an antioxidant, glutathione protects the cell from
oxidative stress by reducing the disulfide bonds of cyto-
plasmic proteins and in the process is oxidized to form
glutathione disulfide (GSSG) [48]. Interestingly, in Met+
media the abundance of GSH is twice as much in
MB468 as compared to MB468res-R8 despite similar
levels of GSSG (Fig. 6k). After culturing in Met-Hcy+
media, both cell lines experience oxidative stress as indi-
cated by increasing levels of GSSG and a steep increase
in GSH, presumably to combat oxidative pressure. The
timing of this transition to the transsulfuration pathway
and glutathione synthesis occurred within 4 h post media
switch in MB468res-R8 cells and by 12 h in MB468 cells.
This timing mirrors the increases of labeled cystathionine
in both cell lines (Fig. 6d), supporting the hypothesis that
redirection of homocysteine metabolism to transsulfura-
tion is due to the cellular need to balance redox potentials.
Cysteine abundances could not be analyzed by stable
isotope tracer studies because metabolic processing of
cystathionine results in an unlabeled molecule of cysteine
and a deuterium-labeled alpha-ketobutyrate molecule.
However, using an untargeted approach, cysteine levels
indicate a similar increase as compared to both glutathi-
one and cystathionine with peak abundances at 8 h in
MB468 and 4 h in MB468res-R8 cells post media switch
(Fig. 6l).
The oxidative stress associated with Met-Hcy+ media
is not unexpected as studies on atherosclerosis have
identified a relationship between elevated homocysteine
levels in plasma and oxidative stress in tissue [49]. The
observed stress may be attributed to auto-oxidation of
homocysteine, which generates hydrogen peroxide and
reactive oxygen species (ROS). Alternatively, the source
of stress may be related to inhibition of ATP synthesis in
the mitochondria. N-methyl-D-aspartate (NMDA) re-
ceptors are glutamate and glycine-activated calcium
channels that are largely found in neurons. Recent stud-
ies have identified active NMDA receptors in human
neuroblastoma cells, small-cell lung cancer cells, and
(See figure on previous page.)
Fig. 6 Homocysteine metabolism is redirected toward the transsulfuration pathway during methionine stress. a A schematic summarizing isotope
tracer results. The majority of deuterium atoms labeled homocysteine and cystathionine, indicating a greater flux toward glutathione synthesis
(green). Methionine and SAM abundances decreases (red) in both cell lines. SAH levels increase (blue) in MB468 cells only. The activated methyl group of
SAM is highlighted with yellow. b Deuterated homocysteine (Hcy-d4(3,3,4,4), dashed square) was used to prepare Met-Hcy+ media for isotope tracer analysis.
Metabolite structures with blue circles indicate the expected location of the deuterium atoms. Mass isotopomer distributions (MID) were calculated using
the Fiehnlab MID Analyzer and validated by comparing spectra of enriched molecules to non-labeled spectra. MIDs for M+0 (black) non-labeled parent
molecule and M+4 (blue), corresponding to a mass shift resulting from four deuterium atoms, are plotted for c homocysteine, d cystathionine, e
methionine, f S-adenosylmethionine (SAM), and g S-adenosylhomocysteine (SAH) for MB468 and MB468res-R8 cells. h Adenosine levels for MB468
(blue) and MB468res-R8 (yellow) cells were measured by GCTOFMS. Error bars represent standard deviation. i SAM (yellow triangles) and SAH (blue circles)
levels were measured by HILIC-UHPLC-qTOFMS in MB468 and MB468res-R8 cells. Scatter plots represent peak heights for individual replicates. The
overlaid line graph (SAM, yellow, SAH, blue) indicates average peak heights. A minimum of two replicates were measured per sample.
j MB468 and MB468res-R8 cells cultured in Met+ (“M”) or Met-Hcy+ (“H”) media were analyzed for methionine adenosyltransferase 2A and
2B (MAT2A, MAT2B) by immunoblot. k Glutathione pools are shown for MB468 and MB468res-R8 cells. Reduced (GSH, blue circles) and oxidized
(GSSG, yellow triangles) glutathione species are plotted for each time point post Met-Hcy+ media switch; horizontal bars indicate averages for each replica
set. Ratios of GSH/GSSG are listed above each time point. l Cysteine levels for MB468 (blue) and MB468res-R8 (yellow) cells were measured by GCTOFMS.
Error bars represent standard deviation
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breast cancer cells and tumors, but not normal tissues
[50, 51]. Free and reduced homocysteine molecules can
bind to NMDA receptors at the glutamate binding loca-
tion and activate an influx of calcium ions resulting in
reduced ATP synthesis, reduced oxidative phosphoryl-
ation, and an accumulation of ROS [52]. Although this
is a suggested mechanism for Met-Hcy+-induced oxida-
tive stress, the loss of oxidative phosphorylation activity
is evident in both cell lines (Fig. 2) and the response to
counter an oxidative insult by increasing glutathione
abundance supports this scenario (Fig. 6k).
In addition to reduced glutathione ratios, the presence
of oxidized lipids becomes more prevalent upon Met-
Hcy+ media switch. The FLIM approach can effectively
visualize and measure oxidized lipids at the single cell
and sub-cellular level. Oxidized lipids are detected by a
long fluorescence lifetime (LLS) and serve as biomarkers
for oxidative stress (Fig. 7a) [53]. To quantify the LLS
fraction in each field, we used phasor cluster analysis of
MB468 and MB468res-R8 cells cultured in Met-Hcy+
media over the course of 48 h (Fig. 7b). In normal Met+
culturing conditions, the average fraction of LLS in
MB468 cells is 7 and 22 % in MB468res-R8 cells (Fig. 7c).
Immediately after media switch to Met-Hcy+, the frac-
tion of LLS increases in MB468 to 25 % at 30 min and
continues to increase over time to an average of 36 % at
48 h. In contrast, MB468res-R8 cells respond to the
media shift with a 5 % average increase to 27 % LLS after
48 h. It is interesting to note the higher level of oxidized
lipids in MB468res-R8 cells in Met+ as compared to
MB468 cells and yet the striking increase observed in
the MB468 cells over time in Met-Hcy+. The biological
functions of these LLS species are not known but are
speculated to serve a protective function that shields
cells from oxidative damage due to the sequestering of
oxidized lipid in vesicles.
Conclusions
In conclusion, the present study reveals dynamic changes
in the metabolic phenotype associated with methionine
dependency of breast cancer and further highlights the
importance of SAM as a major regulator of tumorigenesis.
Importantly, using a labeled precursor, we discovered that
in both MB468 and MB468res-R8 cell types, homocyst-
eine does not significantly contribute to formation of me-
thionine and ultimately S-adenosylmethionine. Our study
indicates that SAM metabolism, which is required for all
methylation reactions, depends on availability of methio-
nine in the cancer cell lines investigated and cannot be
substituted by homocysteine-forming pathways. Moreover,
Fig. 7 Methionine stress induces an increase in oxidative stress. a Two-photon fluorescence intensity images of individual MB468 and MB468res-
R8 cells in Met+ or Met-Hcy+ media (48 h). Pixels within three groups in the phasor histogram have been isolated and colored accordingly in the
FLIM map image. Higher free/bound NADH ratios are highlighted in green, indicating a more reduced state in the nucleus. Lower free/bound
NADH ratios are highlighted in blue, indicating higher ratios of oxidative phosphorylation versus glycolysis in the mitochondria/cytoplasm. Long
lifetime species (LLS) are highlighted in red, indicating the presence of oxidized lipids in the cell. b Phasor histograms of MB468 and MB468res-R8
cells. The black box selects the phasors with LLS signature. c A boxplot representing the percentage of pixels with the LLS (oxidized lipids) signature in
MB468 (blue) and MB468res-R8 (yellow) in in Met-Hcy+ over a 48 h time course
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these findings shed light on the metabolic reprogramming,
which accompanies methionine stress beyond methylation
potential. Such knowledge is instrumental for elucidating
novel targets of therapeutic intervention, which can be
exploited in future studies. Given the importance of SAM
in lipid biogenesis and our observed changes in LLS,
assessing the impact of methionine stress on lipid com-
position and synthesis is of considerable interest and war-
rants further investigation.
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